최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기藥劑學會誌 = Journal of Korean pharmaceutical sciences, v.35 no.3, 2005년, pp.173 - 177
Chun, Myung-Kwan (College of Pharmacy, Chosun University) , Choi, Hoo-Kyun (Research Center for Resistant Cells)
Addition of 30% propylene glycol was required to maintain sink condition in the evaluation of percutaneous absorption of estradiol and norethindrone acetate. The permeability of estradiol was higher in silicone and SIS adhesives. However, estradiol was crystallized in silicone, SIS, and SBS adhesive...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
C. Grant, A. Gray, R. Paoletti, et al., Hormone replacement therapy, The Lancet, 354, 152-155 (1999)
E. Grodstein, M.J. Stampfer, J.E. Manson, G.A. Colditz, W.C. Willett, B. Rosner, EE. Speizer and C.H. Hennekens, Postmenopausal estrogen and progestin use and the risk of cardiovascular disease, N. Engl. J. Med. 335, 453-461 (1996)
C. Castelo-Branco, M.J. Martinez de Osaba, F. Pons and J. Gonzalez-Merlo, The effect of hormone replacement therapy on postmenopausal bone loss, Eur. J. Obstetr. Gynecol. Reprod. Biol. 44, 131-136 (1992)
E. Barrett-Connor and D. Gray, Hormone replacement therapy, heart disease, and other considerations, Annu. Rev. Public health, 19, 55-72 (1998)
M.J. Stampfer, G.A. Colditz, W.C. Willett, J.E. Manson, B. Rosner, E.E. Speizer and C.H. Hennekens, Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study, N Engl. J. Med. 325, 756-762 (1991)
H.K. Genant, J. Lucas, S. Weiss, M. Akin, R. Enkey, H. Mcnaney-Flint, R. Downs, J. Mortola, N. Watts, H.M. Yang, N. Banar, J.J. Brennan and J.C. Nolan, Low-dose esterified estrogen therapy: effects on bone, plasma estradiol concentrations, endometrium, and lipid levels. Estratab/Osteoporosis Study, Arch. Intern. Med. 157, 2609-2615 (1997)
T. Holst and B. Salbach, Efficacy of a new 7 -day transdermal sequential estradiol/levonorgestrel patch in women, Maturitas, 41, 231-242 (2002)
R. Rossi, G. Origliani and M.G Modena, Transdermal 17-betaestradiol and risk of developing type 2 diabetes in a population of healthy, nonobese postmenopausal women, Diabetes Care. 27, 645-649 (2004)
M.S. Post, M.J. van der Moorenvan, W.M. Baal, M.A. Blankenstein, H.M. Merkus, M.Y. Kroeks, H.R. Franke, P. Kenemans and CD. Stehouwer, Effects of low-dose oral and transdermal estrogen replacement therapy on hemostatic factors in healthy postmenopausal women: A randomized placebo-controlled study, Am. J. Obstet. Gynecoz. 189, 1221-1227 (2003)
E. Weiderpass, H.O. Adami, J.A. Baron, C. Magnusson, R. Bergstrom, A. Lindgren, N. Correia and J. Persson, Risk of endometrial cancer following estrogen replacement with and without progestins, J. Natl. Cancer Inst. 91, 1131-1137 (1999)
M. Hori, et al., Classification of percutaneous penetration enhancers. In: R.L. Bronaugh, H.I. Maibach Editors, Percutaneous Absorption: Mechanisms, Methodology, Drug Delivery, Marcel Dekker, New York, USA, pp. 197-211 (1989)
J.-H. Kim, C.H. Lee and H.-K. Choi, Transdennal delivery of physostigmine: Effects of enhancers and pressure sensitive adhesives, Drug Dev. Ind. Pharm., 28, 833-839 (2002)
T. Kokubo, K. Sugibayashi and Y. Morimoto, Interaction between drugs and pressure-sensitive adhesive in transdermal therapeutic systems, Pharm. Res. 11, 104-107 (1994)
J.-H. Kim, Y.-J. Cho and H.-K. Choi, Effect of vehicles and pressure sensitive adhesives in the permeation for tacrine across hairless mouse skin, Int. J. Pharm. 196, 105-113 (2000)
H.-K. Choi and J.T. Angello, Mathematical analysis and optimization of flow-through diffusion cell system. Pharm. Res. 11, 595-599 (1994)
X. Ma, J. Taw and C.M. Chiang, Control of drug crystallization in transdermal matrix system, Int. J. Pharm. 142, 115-119 (1996)
D.R. Friend and P. Catz, Effect of cosolvents on ethyl acetate enhanced percutaneous absorption of levonorgestrel, J. Control. Release, 12, 171-180 (1990)
G.S. Chen, D.O. Kim and Y.W. Chien, Dual-controlled transdermal delivery of levonorgestrel and estradiol: enhanced permeation and modulated delivery, J. Control. Release, 34, 129-143 (1995)
L.K. Pershing, G.E. Parry and L.D. Lambert, Disparity of in vitro and in vivo oleic acid-enhanced ${\beta}$ -estradiol percutaneous absorption across human skin, Pharm. Res. 10, 1745-1750 (1993)
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.